Drugmakers Expected To Adopt Voluntary Restrictions On Direct-To-Consumer Advertising The pharmaceutical industry this week is expected to announce voluntary restrictions on direct-to-consumer drug advertising, the Wall Street Journal reports. The Pharmaceutical Research and Manufacturers Association will disclose restrictions that include suggesting drugmakers consider implementing a minimum time period before launching advertising for newly approved
drugs.
Source: www.medicalnewstoday.comIMS Health Reports Annual Global Generics Prescription Sales Growth Of 3.6 Percent, To $78 Billion Global
prescription sales growth of generics
drugs slowed to 3.6 percent in the twelve months ending September 2008, down from 11.4 percent in 2007, according to a new report by IMS
Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and
healthcare industries.
Source: www.medicalnewstoday.comMany Drug Overdose Deaths Due To Non-Medical Use Of Prescription Pain Medication In an examination of unintentional overdose deaths in the state of West Virginia, a majority of these have been found to be associated with the nonmedical use and diversion of
prescription drugs, especially pain relievers, according to an article released on December 9, 2008 in JAMA.
Source: www.medicalnewstoday.comStudy Showed New Episodes Of Depression Delayed In People Taking Cymbalta(R) .New data suggest that Cymbalta (duloxetine HCl) 60 mg to 120 mg once daily delayed the onset of a new episode of depression in patients who had previously responded to the medication and who had recurrent depressive disorder, defined in the study as those patients who experienced at least three depressive episodes in the previous five years, compared with placebo (p
Source: www.medicalnewstoday.com
# posted by Network @ 3:00 PM